Trial intelligence / Profile preview

Fluticasone Propionate in Seasonal Allergic Rhinitis (VCC and Park Models)

NCT00400998Phase 2Completed

Start
Mar 2006
Primary completion
Nov 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Fluticasone Propionate with Placebo (2 arms). Primary endpoint: Major Symptom Complex. Started Mar 2006; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00400998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00400998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call